Literature DB >> 28181516

Progress on the Neuroscience-Based Nomenclature (NbN) for Psychotropic Medications.

Pierre Blier1, Maria A Oquendo2, David J Kupfer3.   

Abstract

Year:  2017        PMID： 28181516      PMCID： PMC5561343          DOI： 10.1038/npp.2017.33

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN： 0893-133X            Impact factor:   7.853


× No keyword cloud information.
  3 in total

Review 1.  A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature.

Authors:  Joseph Zohar; Stephen Stahl; Hans-Jurgen Moller; Pierre Blier; David Kupfer; Shigeto Yamawaki; Hiroyuki Uchida; Michael Spedding; Guy M Goodwin; David Nutt
Journal:  Eur Neuropsychopharmacol       Date:  2015-09-07       Impact factor: 4.600

2.  Beyond psychoanaleptics - can we improve antidepressant drug nomenclature?

Authors:  D J Nutt
Journal:  J Psychopharmacol       Date:  2009-06       Impact factor: 4.153

3.  Classifying psychotropic drugs by mode of action and not by target disorder.

Authors:  Stephen M Stahl
Journal:  CNS Spectr       Date:  2013-06       Impact factor: 3.790
  3 in total
  1 in total

1.  Innovations in Psychopharmacology Education in U.S. Psychiatric Residency Programs.

Authors:  Jeffrey Rakofsky
Journal:  Focus (Am Psychiatr Publ)       Date:  2021-01-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.